396 related articles for article (PubMed ID: 22456695)
1. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
Hage C; Lundman P; Rydén L; Mellbin L
Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
[TBL] [Abstract][Full Text] [Related]
2. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
[TBL] [Abstract][Full Text] [Related]
3. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.
Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP
Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499
[TBL] [Abstract][Full Text] [Related]
4. Editor's Choice- Diagnosis of type 2 diabetes and prediabetes among patients with acute coronary syndromes.
Bjarnason TA; Kristinsdottir LB; Oskarsdottir ES; Hafthorsson SO; Olafsson I; Lund SH; Andersen K
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):744-749. PubMed ID: 27625341
[TBL] [Abstract][Full Text] [Related]
5. Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project.
Ye N; Yang L; Wang G; Bian W; Xu F; Ma C; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
BMC Cardiovasc Disord; 2020 Aug; 20(1):380. PubMed ID: 32819275
[TBL] [Abstract][Full Text] [Related]
6. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342
[TBL] [Abstract][Full Text] [Related]
7. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
[TBL] [Abstract][Full Text] [Related]
8. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
[TBL] [Abstract][Full Text] [Related]
9. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG
J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894
[TBL] [Abstract][Full Text] [Related]
10. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
[TBL] [Abstract][Full Text] [Related]
11. Comparison of HbA1c and OGTT for the diagnosis of type 2 diabetes in children at risk of diabetes.
Kim MS; Jo DS; Lee DY
Pediatr Neonatol; 2019 Aug; 60(4):428-434. PubMed ID: 30497969
[TBL] [Abstract][Full Text] [Related]
12. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
[TBL] [Abstract][Full Text] [Related]
13. Predicting dysglycaemia in patients under investigation for acute coronary syndrome.
Tahrani AA; Geen J; Hanna FW; Jones PW; Cassidy D; Bates D; Fryer AA
QJM; 2011 Mar; 104(3):231-6. PubMed ID: 20934980
[TBL] [Abstract][Full Text] [Related]
14. Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke.
Matz K; Tuomilehto J; Teuschl Y; Dachenhausen A; Brainin M
Cardiovasc Diabetol; 2020 Dec; 19(1):204. PubMed ID: 33278898
[TBL] [Abstract][Full Text] [Related]
15. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting.
Kengne AP; Erasmus RT; Levitt NS; Matsha TE
Prim Care Diabetes; 2017 Apr; 11(2):119-131. PubMed ID: 28132763
[TBL] [Abstract][Full Text] [Related]
16. Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities--the BEGAMI study.
Hage C; Brismar K; Efendic S; Lundman P; Rydén L; Mellbin L
J Intern Med; 2013 Apr; 273(4):410-21. PubMed ID: 23331339
[TBL] [Abstract][Full Text] [Related]
17. HbA1c predicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose.
Geberhiwot T; Haddon A; Labib M
Ann Clin Biochem; 2005 May; 42(Pt 3):193-5. PubMed ID: 15949153
[TBL] [Abstract][Full Text] [Related]
18. Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome.
de Mulder M; Oemrawsingh RM; Stam F; Boersma E; Umans VA
Heart; 2012 Jan; 98(1):37-41. PubMed ID: 21708819
[TBL] [Abstract][Full Text] [Related]
19. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.
Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Sundvall J; Tuomilehto J; Wood D; Rydén L;
Eur Heart J; 2015 May; 36(19):1171-7. PubMed ID: 25670820
[TBL] [Abstract][Full Text] [Related]
20. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
